Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL976623

N.N#CCOP(=O)([O-])[O-].[H+].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926219 0.97
Potassium Ion SCHEMBL3897706 0.95
SCHEMBL937334 0.95
Potassium Ion SCHEMBL3131828 0.92
Potassium Ion SCHEMBL5803916 0.82 SLC34A1 (0.32)
SCHEMBL9098975 0.78
Tetrabuthylammonium SCHEMBL2824667 0.75 SLC22A1 (0.41)
Potassium Ion SCHEMBL5689772 0.73
Ammonia Solution, Strong SCHEMBL4523855 0.72 TPI1 (0.34)
Ammonia Solution, Strong SCHEMBL10847788 0.72 TPI1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2185138-B1 SOLID PREPARATION COMPRISING ALOGLIPTIN AND METFORMIN HYDROCHLORIDE TAKEDA PHARMACEUTICAL (JP) 2016-09-07 EP disclosed
US-20110014299-A2 SOLID PREPARATION COMPRISING ALOGLIPTIN AND METFORMIN HYDROCHLORIDE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-20 US disclosed
EP-2185138-A1 SOLID PREPARATION COMPRISING ALOGLIPTIN AND METFORMIN HYDROCHLORIDE Takeda Pharmaceutical Company Limited (JP) 2010-05-19 EP disclosed
WO-2009011451-A1 SOLID PREPARATION COMPRISING ALOGLIPTIN AND METFORMIN HYDROCHLORIDE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-22 WO disclosed